These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 36067080)

  • 21. Prevalence, predictors, and outcomes of advance directives in implantable cardioverter-defibrillator recipients.
    Merchant FM; Binney Z; Patel A; Li J; Peddareddy LP; El-Chami MF; Leon AR; Quest T
    Heart Rhythm; 2017 Jun; 14(6):830-836. PubMed ID: 28232262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implantable cardioverter-defibrillator: present and future indications.
    Block M; Scheld H; Breithardt G
    Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():141-7. PubMed ID: 8734176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of implantable cardioverter defibrillators in Canadian and US survivors of out-of-hospital cardiac arrest.
    Birnie DH; Sambell C; Johansen H; Williams K; Lemery R; Green MS; Gollob MH; Lee DS; Tang AS
    CMAJ; 2007 Jul; 177(1):41-6. PubMed ID: 17606938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Posttraumatic stress disorder and mortality in VA patients with implantable cardioverter-defibrillators.
    Ofman P; Hoffmeister P; Kaloupek DG; Gagnon DR; Peralta A; Djousse L; Gaziano JM; Rahilly-Tierney CR
    Clin Cardiol; 2018 May; 41(5):652-659. PubMed ID: 29532498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors associated with health-related quality of life among patients with implantable cardioverter defibrillator: identification of foci for nursing intervention.
    Wong FM; Sit JW; Wong EM; Choi KC
    J Adv Nurs; 2014 Dec; 70(12):2821-34. PubMed ID: 24754723
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early mortality in prophylactic implantable cardioverter-defibrillator recipients: development and validation of a clinical risk score.
    Kraaier K; Scholten MF; Tijssen JG; Theuns DA; Jordaens LJ; Wilde AA; van Dessel PF
    Europace; 2014 Jan; 16(1):40-6. PubMed ID: 23918791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ICD: a qualitative study of patient experience the first year after implantation.
    Kamphuis HC; Verhoeven NW; Leeuw R; Derksen R; Hauer RN; Winnubst JA
    J Clin Nurs; 2004 Nov; 13(8):1008-16. PubMed ID: 15533107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Palliative Care Consultation and Associated End-of-Life Care After Pacemaker or Implantable Cardioverter-Defibrillator Deactivation.
    Pasalic D; Gazelka HM; Topazian RJ; Buchhalter LC; Ottenberg AL; Webster TL; Swetz KM; Mueller PS
    Am J Hosp Palliat Care; 2016 Dec; 33(10):966-971. PubMed ID: 26169518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of Inappropriate Shocks and Other Health Outcomes Between Single- and Dual-Chamber Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter-Defibrillators.
    Peterson PN; Greenlee RT; Go AS; Magid DJ; Cassidy-Bushrow A; Garcia-Montilla R; Glenn KA; Gurwitz JH; Hammill SC; Hayes J; Kadish A; Reynolds K; Sharma P; Smith DH; Varosy PD; Vidaillet H; Zeng CX; Normand ST; Masoudi FA
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29122811
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator.
    Klein HU; Goldenberg I; Moss AJ
    Eur Heart J; 2013 Aug; 34(29):2230-42. PubMed ID: 23729691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
    Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C
    Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators.
    Bardy GH; Yee R; Jung W
    J Am Coll Cardiol; 1996 Aug; 28(2):400-10. PubMed ID: 8800117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential cost-effectiveness of wearable cardioverter-defibrillator for patients with implantable cardioverter-defibrillator explant in a high-income city of China.
    Jiang X; Ming WK; You JHS
    J Cardiovasc Electrophysiol; 2019 Nov; 30(11):2387-2396. PubMed ID: 31502350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sleep disturbance in patients with an implantable cardioverter defibrillator: Prevalence, predictors and impact on health status.
    Habibović M; Mudde L; Pedersen SS; Schoormans D; Widdershoven J; Denollet J
    Eur J Cardiovasc Nurs; 2018 Jun; 17(5):390-398. PubMed ID: 29260886
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Developing a risk model for in-hospital adverse events following implantable cardioverter-defibrillator implantation: a report from the NCDR (National Cardiovascular Data Registry).
    Dodson JA; Reynolds MR; Bao H; Al-Khatib SM; Peterson ED; Kremers MS; Mirro MJ; Curtis JP;
    J Am Coll Cardiol; 2014 Mar; 63(8):788-96. PubMed ID: 24333491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of age on quality of life in implantable cardioverter defibrillator recipients.
    Hamilton GA; Carroll DL
    J Clin Nurs; 2004 Feb; 13(2):194-200. PubMed ID: 14723671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors influencing health-related quality of life in patients with an implantable cardioverter defibrillator: A systematic review.
    Wong F; Sit J; Wong E
    JBI Libr Syst Rev; 2012; 10(43):2785-2881. PubMed ID: 27820203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experiences of adults living with an implantable cardioverter defibrillator for cardiovascular disease: a systematic review of qualitative evidence.
    Pike A; Dobbin-Williams K; Swab M
    JBI Evid Synth; 2020 Nov; 18(11):2231-2301. PubMed ID: 32813405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes in African Americans undergoing cardioverter-defibrillator implantation for primary prevention of sudden cardiac death: findings from the Prospective Observational Study of Implantable Cardioverter-Defibrillators (PROSE-ICD).
    Zhang Y; Kennedy R; Blasco-Colmenares E; Butcher B; Norgard S; Eldadah Z; Dickfeld T; Ellenbogen KA; Marine JE; Guallar E; Tomaselli GF; Cheng A
    Heart Rhythm; 2014 Aug; 11(8):1377-83. PubMed ID: 24793459
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disparities in the use of primary prevention and defibrillator therapy among blacks and women.
    Gauri AJ; Davis A; Hong T; Burke MC; Knight BP
    Am J Med; 2006 Feb; 119(2):167.e17-21. PubMed ID: 16443424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.